![]() | EXHIBIT 99.1 | |||
3Q 2026 Earnings Release | ||||
FOR IMMEDIATE RELEASE | October 30, 2026 | |||
Results Summary | ||||||
3Q26 | 2Q26 | Change vs 2Q26 | Dollars in millions (except per share data) | YTD 2026 | YTD 2025 | Change vs YTD 2025 |
15,413 | 14,525 | +888 | Earnings (U.S. GAAP) | 34,121 | 22,343 | +11,778 |
17,505 | 14,680 | +2,825 | Adjusted Earnings/(Loss) (Non-GAAP) | 40,957 | 22,457 | +18,500 |
3.72 | 3.48 | +0.24 | Earnings Per Common Share (U.S. GAAP) ¹ | 8.18 | 5.16 | +3.02 |
4.23 | 3.52 | +0.71 | Adjusted Earnings/(Loss) Per Common Share (Non-GAAP) ¹ | 9.82 | 5.19 | +4.63 |
![]() | ||||
EARNINGS AND VOLUME SUMMARY BY SEGMENT | ||||
3Q26 | 2Q26 | Dollars in millions (unless otherwise noted) | YTD 2026 | YTD 2025 |
Earnings/(Loss) (U.S. GAAP) | ||||
7,088 | 7,927 | Upstream | 20,752 | 17,837 |
7,169 | 5,465 | Energy Products | 11,372 | 4,033 |
735 | 1,131 | Chemical Products | 1,976 | 1,081 |
1,285 | 956 | Specialty Products | 2,892 | 2,175 |
(864) | (954) | Corporate and Financing | (2,871) | (2,783) |
15,413 | 14,525 | Total Earnings/(Loss) (U.S. GAAP) | 34,121 | 22,343 |
Adjusted Earnings/(Loss) (Non-GAAP) | ||||
7,308 | 9,189 | Upstream | 22,762 | 17,511 |
9,053 | 4,099 | Energy Products | 15,951 | 3,963 |
725 | 1,214 | Chemical Products | 2,049 | 1,081 |
1,283 | 969 | Specialty Products | 2,903 | 2,175 |
(864) | (791) | Corporate and Financing | (2,708) | (2,273) |
17,505 | 14,680 | Total Adjusted Earnings/(Loss) (Non-GAAP) | 40,957 | 22,457 |
Volumes | ||||
4,496 | 4,514 | Upstream Production (koebd) | 4,534 | 4,651 |
5,753 | 5,698 | Energy Products Sales (kbd) | 5,694 | 5,522 |
4,888 | 4,471 | Chemical Products Sales (kt) | 14,717 | 15,560 |
1,737 | 1,784 | Specialty Products Sales (kt) | 5,497 | 5,872 |
![]() | ||||
CASH FLOW FROM OPERATIONS EXCLUDING WORKING CAPITAL | ||||
3Q26 | 2Q26 | Dollars in millions (unless otherwise noted) | YTD 2026 | YTD 2025 |
16,022 | 14,881 | Net income/(loss) including noncontrolling interests | 35,375 | 23,155 |
6,803 | 8,689 | Depreciation and depletion (includes impairments) | 22,263 | 18,278 |
2,216 | (2,099) | Changes in operational working capital, excluding cash and debt | (1,641) | (5,000) |
609 | 2,084 | Other | 1,913 | 2,858 |
25,650 | 23,555 | Cash Flow from Operating Activities (U.S. GAAP) | 57,910 | 39,291 |
(2,216) | 2,099 | Less: Changes in operational working capital, excluding cash and debt | 1,641 | 5,000 |
23,434 | 25,654 | Cash Flow from Operations excluding Working Capital (Non-GAAP) | 59,551 | 44,291 |
FREE CASH FLOW | ||||
3Q26 | 2Q26 | Dollars in millions (unless otherwise noted) | YTD 2026 | YTD 2025 |
25,650 | 23,555 | Cash Flow from Operating Activities (U.S. GAAP) | 57,910 | 39,291 |
(7,178) | (6,527) | Additions to property, plant, and equipment | (20,175) | (20,908) |
(868) | (324) | Additional investments and advances | (1,579) | (973) |
697 | 102 | Other investing activities including collection of advances | 1,431 | 949 |
808 | 430 | Proceeds from asset sales and returns of investments | 1,457 | 2,138 |
— | — | Inflows from noncontrolling interest for major projects | — | 68 |
19,109 | 17,236 | Free Cash Flow (Non-GAAP) | 39,044 | 20,565 |
![]() | ||||
CASH CAPITAL EXPENDITURES | ||||
3Q26 | 2Q26 | Dollars in millions (unless otherwise noted) | YTD 2026 | YTD 2025 |
7,178 | 6,527 | Additions to property, plant, and equipment | 20,175 | 20,908 |
868 | 324 | Additional investments and advances | 1,579 | 973 |
(697) | (102) | Other investing activities including collection of advances | (1,431) | (949) |
— | — | Inflows from noncontrolling interests for major projects | — | (68) |
(347) | 38 | Less: Advances and collections not related to capital expenditures or equity investments | (347) | 270 |
7,002 | 6,787 | Total Cash Capital Expenditures (Non-GAAP) | 19,976 | 21,134 |
3Q26 | 2Q26 | Dollars in millions (unless otherwise noted) | YTD 2026 | YTD 2025 |
Upstream | ||||
3,948 | 3,423 | United States | 10,820 | 12,233 |
2,033 | 2,429 | Non-U.S. | 5,825 | 6,043 |
5,981 | 5,852 | Total | 16,645 | 18,276 |
Energy Products | ||||
227 | 331 | United States | 1,386 | 463 |
254 | 196 | Non-U.S. | 620 | 789 |
481 | 527 | Total | 2,006 | 1,252 |
Chemical Products | ||||
216 | 263 | United States | 635 | 505 |
31 | 44 | Non-U.S. | 101 | 340 |
247 | 307 | Total | 736 | 845 |
Specialty Products | ||||
120 | 18 | United States | 173 | 160 |
35 | (7) | Non-U.S. | 48 | 156 |
155 | 11 | Total | 221 | 316 |
Other | ||||
138 | 90 | Other | 368 | 445 |
7,002 | 6,787 | Worldwide | 19,976 | 21,134 |
![]() | ||||||
CALCULATION OF STRUCTURAL COST SAVINGS | ||||||
Dollars in billions (unless otherwise noted) | Twelve Months Ended December 31, | Nine Months Ended September 30, | ||||
2019 | 2025 | 2025 | 2026 | |||
Components of Operating Costs | ||||||
From ExxonMobil’s Consolidated Statement of Income (U.S. GAAP) | ||||||
Production and manufacturing expenses | 36.8 | 42.4 | 30.3 | 34.2 | ||
Selling, general and administrative expenses | 11.4 | 11.1 | 8.1 | 7.8 | ||
Depreciation and depletion (includes impairments) | 19.0 | 26.0 | 18.3 | 22.3 | ||
Exploration expenses, including dry holes | 1.3 | 1.0 | 0.5 | 0.4 | ||
Non-service pension and postretirement benefit expense | 1.2 | 0.4 | 0.3 | 0.1 | ||
Subtotal | 69.7 | 81.0 | 57.4 | 64.7 | ||
ExxonMobil’s share of equity company expenses (Non-GAAP) | 9.1 | 10.6 | 7.8 | 6.2 | ||
Total Adjusted Operating Costs (Non-GAAP) | 78.8 | 91.6 | 65.3 | 70.9 | ||
Less: | ||||||
Depreciation and depletion (includes impairments) | 19.0 | 26.0 | 18.3 | 22.3 | ||
Non-service pension and postretirement benefit expense | 1.2 | 0.4 | 0.3 | 0.1 | ||
Other adjustments (includes equity company depreciation and depletion) | 3.6 | 6.2 | 3.7 | 5.7 | ||
Total Cash Operating Expenses (Cash Opex) (Non-GAAP) | 55.0 | 59.0 | 43.0 | 42.9 | ||
Energy and production taxes (Non-GAAP) | 11.0 | 14.9 | 11.2 | 9.9 | ||
Total Cash Operating Expenses (Cash Opex) excluding Energy and Production Taxes (Non-GAAP) | 44.0 | 44.1 | 31.8 | 33.0 | ||
Change vs 2019 | Change vs 2025 | Estimated Cumulative vs 2019 | ||||
Total Cash Operating Expenses (Cash Opex) excluding Energy and Production Taxes (Non-GAAP) | +0.1 | +1.2 | ||||
Market | +4.9 | +1.2 | ||||
Activity/ Other | +10.3 | +1.8 | ||||
Structural Cost Savings | -15.1 | -1.8 | -16.9 | |||
![]() | ||||
KEY FIGURES: ADJUSTING ITEMS | ||||
3Q26 | 2Q26 | Dollars in millions (unless otherwise noted) | YTD 2026 | YTD 2025 |
15,413 | 14,525 | Earnings/(Loss) (U.S. GAAP) | 34,121 | 22,343 |
Identified Items | ||||
— | (1,079) | Impairments | (1,079) | (155) |
675 | — | Gain/(Loss) on sale of assets | 675 | — |
— | — | Restructuring charges | — | (355) |
(226) | (1,559) | Other ¹ | (2,491) | — |
449 | (2,638) | Total Identified Items | (2,895) | (510) |
(2,541) | 2,483 | Estimated Timing Effects | (3,941) | 396 |
17,505 | 14,680 | Adjusted Earnings/(Loss) (Non-GAAP) | 40,957 | 22,457 |
1 2Q26 Other Identified Items includes $1,365 million in additions to financial reserves and $194 million in Middle East impacts; YTD 2026 Other Identified Items includes $1,570 million in additions to financial reserves and $921 million in Middle East impacts. | ||||
ADJUSTING ITEMS PER COMMON SHARE | ||||
3Q26 | 2Q26 | Dollars per common share | YTD 2026 | YTD 2025 |
3.72 | 3.48 | Earnings/(Loss) Per Common Share (U.S. GAAP) ¹ | 8.18 | 5.16 |
Identified Items Per Common Share ¹ | ||||
— | (0.26) | Impairments | (0.26) | (0.04) |
0.16 | — | Gain/(Loss) on sale of assets | 0.16 | — |
— | — | Restructuring charges | — | (0.08) |
(0.05) | (0.37) | Other | (0.60) | — |
0.11 | (0.63) | Total Identified Items Per Common Share ¹ | (0.69) | (0.12) |
(0.61) | 0.59 | Estimated Timing Effects Per Common Share ¹ | (0.94) | 0.09 |
4.23 | 3.52 | Adjusted Earnings/(Loss) Per Common Share (Non-GAAP) ¹ | 9.82 | 5.19 |
¹ Assuming dilution. | ||||
![]() | ||||||||||
KEY FIGURES: ADJUSTING ITEMS BY SEGMENT | ||||||||||
Third Quarter 2026 | Upstream | Energy Products | Chemical Products | Specialty Products | Corporate & Financing | Total | ||||
Dollars in millions (unless otherwise noted) | U.S. | Non-U.S. | U.S. | Non-U.S. | U.S. | Non-U.S. | U.S. | Non-U.S. | ||
Earnings/(Loss) (U.S. GAAP) | 3,201 | 3,887 | 4,787 | 2,382 | 472 | 263 | 386 | 899 | (864) | 15,413 |
Identified Items | ||||||||||
Gain/(Loss) on sale of assets | 675 | — | — | — | — | — | — | — | — | 675 |
Other | (219) | (8) | — | (11) | 7 | 3 | 1 | 1 | — | (226) |
Total Identified Items | 456 | (8) | — | (11) | 7 | 3 | 1 | 1 | — | 449 |
Estimated Timing Effects (Worldwide) | (668) | (1,873) | — | — | — | (2,541) | ||||
Adjusted Earnings/(Loss) (Non-GAAP) | 7,308 | 9,053 | 725 | 1,283 | (864) | 17,505 | ||||
Second Quarter 2026 | Upstream | Energy Products | Chemical Products | Specialty Products | Corporate & Financing | Total | ||||
Dollars in millions (unless otherwise noted) | U.S. | Non-U.S. | U.S. | Non-U.S. | U.S. | Non-U.S. | U.S. | Non-U.S. | ||
Earnings/(Loss) (U.S. GAAP) | 1,920 | 6,007 | 2,987 | 2,478 | 599 | 532 | 287 | 669 | (954) | 14,525 |
Identified Items | ||||||||||
Impairments | — | — | — | (884) | (48) | — | — | — | (147) | (1,079) |
Other ¹ | (1,183) | (16) | (49) | (247) | (6) | (29) | (2) | (11) | (16) | (1,559) |
Total Identified Items | (1,183) | (16) | (49) | (1,131) | (54) | (29) | (2) | (11) | (163) | (2,638) |
Estimated Timing Effects (Worldwide) | (63) | 2,546 | — | — | — | 2,483 | ||||
Adjusted Earnings/(Loss) (Non-GAAP) | 9,189 | 4,099 | 1,214 | 969 | (791) | 14,680 | ||||
¹ 2Q26 Other Identified Items includes $1,365 million in additions to financial reserves and $194 million in Middle East impacts. | ||||||||||
YTD 2026 | Upstream | Energy Products | Chemical Products | Specialty Products | Corporate & Financing | Total | ||||
Dollars in millions (unless otherwise noted) | U.S. | Non-U.S. | U.S. | Non-U.S. | U.S. | Non-U.S. | U.S. | Non-U.S. | ||
Earnings/(Loss) (U.S. GAAP) | 6,695 | 14,057 | 8,435 | 2,937 | 1,390 | 586 | 947 | 1,945 | (2,871) | 34,121 |
Identified Items | ||||||||||
Impairments | — | — | — | (884) | (48) | — | — | — | (147) | (1,079) |
Gain/(Loss) on sale of assets | 675 | — | — | — | — | — | — | — | — | 675 |
Other ¹ | (1,402) | (24) | (49) | (964) | 1 | (26) | (1) | (10) | (16) | (2,491) |
Total Identified Items | (727) | (24) | (49) | (1,848) | (47) | (26) | (1) | (10) | (163) | (2,895) |
Estimated Timing Effects (Worldwide) | (1,259) | (2,682) | — | — | — | (3,941) | ||||
Adjusted Earnings/(Loss) (Non-GAAP) | 22,762 | 15,951 | 2,049 | 2,903 | (2,708) | 40,957 | ||||
¹ YTD 2026 Other Identified Items includes $1,570 million in additions to financial reserves and $921 million in Middle East impacts. | ||||||||||
YTD 2025 | Upstream | Energy Products | Chemical Products | Specialty Products | Corporate & Financing | Total | ||||
Dollars in millions (unless otherwise noted) | U.S. | Non-U.S. | U.S. | Non-U.S. | U.S. | Non-U.S. | U.S. | Non-U.S. | ||
Earnings/(Loss) (U.S. GAAP) | 4,310 | 13,527 | 1,980 | 2,053 | 839 | 242 | 967 | 1,208 | (2,783) | 22,343 |
Identified Items | ||||||||||
Impairments | — | — | — | — | — | — | — | — | (155) | (155) |
Restructuring charges | — | — | — | — | — | — | — | — | (355) | (355) |
Total Identified Items | — | — | — | — | — | — | — | — | (510) | (510) |
Estimated Timing Effects (Worldwide) | 326 | 70 | — | — | — | 396 | ||||
Adjusted Earnings/(Loss) (Non-GAAP) | 17,511 | 3,963 | 1,081 | 2,175 | (2,273) | 22,457 | ||||